Stuart Isaacson

7.2k citations
149 papers · 3.6k · 3 hit papers · h-index 30

Impact in

  • Neurology top 0.2%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Botulinum Toxin and Related Neurological Disorders
    • Neuroscience and Neuropharmacology Research
    • Genetic Neurodegenerative Diseases

Papers in

    • Parkinson's Disease Mechanisms and Treatments 95
    • Neurological disorders and treatments 44
    • Botulinum Toxin and Related Neurological Disorders 26
    • Cardiovascular Syncope and Autonomic Disorders 10

Stuart Isaacson

143 papers receiving 3.5k citations

Stuart Isaacson's Hit Papers

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease 2018 · 234 citations
2340+4+8Years since publication100200300400500

Peers

Stuart Isaacson
Comparison fields: 5 of 114
  • Neurology 2.2k
  • Cellular and Molecular Neuroscience 791
  • Neurology 209
  • Psychiatry and Mental health 282
  • Biological Psychiatry 36
Replace Mark Lew with:
Mark Lew United States
Carlos Singer United States
Masato Asahina Japan
Peter Kempster Australia
Padraig O’Suilleabhain United States
J.F. Martí-Massó Spain
Peter Paul De Deyn Belgium
L. Côté United States
Han Soo Yoo South Korea
Joseph Jankovic United States
Stuart Isaacson relative to Mark Lew United States Mark Lew's profile →
Citations per field
00.5×2×2.6×
Mark Lew · 1×
Citations per year

Countries citing papers authored by Stuart Isaacson

Since Specialization
Citations

This map shows the geographic impact of Stuart Isaacson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Isaacson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Isaacson more than expected).

Fields of papers citing papers by Stuart Isaacson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Isaacson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Isaacson. The network helps show where Stuart Isaacson may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart Isaacson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Isaacson Line = papers co-authored together Stuart Isaacson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
2013547
2
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
Hit paper breakdown →
2017293
3
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
Hit paper breakdown →
2018234
4 2017143
5 2017139
6 2014124
7 2016122
8 2015119
9 201997
10 201994
11 201483
12 199683
13 201665
14 201658
15 202056
16 201550
17 201649
18 201448
19 201846
20 201943

About Stuart Isaacson

Stuart Isaacson is a scholar working on Neurology, Surgery, Psychiatry and Mental health, Epidemiology and Cellular and Molecular Neuroscience, having authored 149 papers that have together received 3.6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (95 papers), Neurological disorders and treatments (44 papers), Botulinum Toxin and Related Neurological Disorders (26 papers), Cardiovascular Syncope and Autonomic Disorders (10 papers), Attention Deficit Hyperactivity Disorder (7 papers), Restless Legs Syndrome Research (6 papers), Pharmaceutical studies and practices (6 papers) and Autism Spectrum Disorder Research (3 papers). The work is most often cited by research in Neurology (2.2k citations), Cellular and Molecular Neuroscience (791 citations), Neurology (209 citations), Psychiatry and Mental health (282 citations) and Biological Psychiatry (36 citations). Stuart Isaacson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert A. Hauser, Rajesh Pahwa, Clive Ballard, Roger Mills, Hilde Williams, Anne Corbett, Kathy Chi‐Burris, Rohit Dhall, Jeffrey L. Cummings and Mark Lew. Their work appears in journals such as Neurology, Parkinsonism & Related Disorders, Journal of Parkinson s Disease, Movement Disorders and JAMA Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact